Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice

Exclusion Criteria

• •1. The participant is medically unfit to undergo upper endoscopy.
• •2. No cancer-directed therapy administered within the last 3 months. This includes any of the following: surgical resection, chemotherapy, radiation therapy, immunologic or biologic therapy.
• •3. Participants with a known allergy to secretin.
• •4. Participants who are pregnant or lactating, or intending to become pregnant during the study.
• •5. Participants of childbearing potential who refuse a pregnancy test.
• •6. Participants who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures.
• •7. Participants who have participated in an investigational surgical, drug, or device study within the past 30 days.
• •8. Participants who currently have a biliary stent in place.
• •9. Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
• •10. The endoscopic pancreatic biopsy does not show adenocarcinoma.
• •Group B:
• •1. The participant is medically unfit to undergo upper endoscopy.
• •2. The participant has a suspicion of pancreatic adenocarcinoma on imaging within the last 3 months.
• •3. Participants with a known allergy to secretin.
• •4. Participants who are pregnant or lactating, or intending to become pregnant during the study.
• •5. Participants of childbearing potential who refuse a pregnancy test.
• •6. Participants who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures.
• •7. Participants who have participated in an investigational surgical, drug, or device study within the past 30 days.
• •8. Participants who currently have a biliary stent in place.
• •9. Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
• •Group C:
• •1. The participant is medically unfit to undergo upper endoscopy.
• •2. The participant has a history of, or current clinical suspicion of pancreatic adenocarcinoma or pancreatitis.
• •3. The participant has a history of any type of gastrointestinal malignancy within the last 5 years.
• •4. Participants with a known allergy to secretin.
• •5. Participants who are pregnant or lactating, or intending to become pregnant during the study.
• •6. Participants of childbearing potential who refuse a pregnancy test.
• •7. Participants who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures.
• •8. Participants who have participated in an investigational surgical, drug, or device study within the past 30 days.
• •9. Participants who currently have a biliary stent in place.
• •10. Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
• •\-